Your browser doesn't support javascript.
loading
Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
Widjaja, Anissa A; Singh, Brijesh K; Adami, Eleonora; Viswanathan, Sivakumar; Dong, Jinrui; D'Agostino, Giuseppe A; Ng, Benjamin; Lim, Wei Wen; Tan, Jessie; Paleja, Bhairav S; Tripathi, Madhulika; Lim, Sze Yun; Shekeran, Shamini Guna; Chothani, Sonia P; Rabes, Anne; Sombetzki, Martina; Bruinstroop, Eveline; Min, Lio Pei; Sinha, Rohit A; Albani, Salvatore; Yen, Paul M; Schafer, Sebastian; Cook, Stuart A.
Affiliation
  • Widjaja AA; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Singh BK; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Adami E; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Viswanathan S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Dong J; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • D'Agostino GA; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Ng B; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
  • Lim WW; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
  • Tan J; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
  • Paleja BS; Translational Immunology Institute, SingHealth/Duke-NUS Academic Medical Centre, Singapore.
  • Tripathi M; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Lim SY; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
  • Shekeran SG; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Chothani SP; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Rabes A; Department of Tropical Medicine and Infectious Diseases, University Medical Center, Rostock, Germany.
  • Sombetzki M; Department of Tropical Medicine and Infectious Diseases, University Medical Center, Rostock, Germany.
  • Bruinstroop E; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Min LP; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
  • Sinha RA; Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
  • Albani S; Translational Immunology Institute, SingHealth/Duke-NUS Academic Medical Centre, Singapore.
  • Yen PM; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
  • Schafer S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
  • Cook SA; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore; National Heart and Lung Institute, Imperial College London, London, UK; MRC-London Institute of Me
Gastroenterology ; 157(3): 777-792.e14, 2019 09.
Article de En | MEDLINE | ID: mdl-31078624
Sujet(s)
Anticorps neutralisants/pharmacologie; Hépatite/prévention et contrôle; Sous-unité alpha du récepteur à l'interleukine-11/métabolisme; Interleukine-11/antagonistes et inhibiteurs; Cirrhose expérimentale/prévention et contrôle; Foie/effets des médicaments et des substances chimiques; Stéatose hépatique non alcoolique/prévention et contrôle; Animaux; Mort cellulaire/effets des médicaments et des substances chimiques; Fibroblastes/effets des médicaments et des substances chimiques; Fibroblastes/métabolisme; Fibroblastes/anatomopathologie; Cellules étoilées du foie/effets des médicaments et des substances chimiques; Cellules étoilées du foie/métabolisme; Cellules étoilées du foie/anatomopathologie; Hépatite/génétique; Hépatite/métabolisme; Hépatite/anatomopathologie; Hépatocytes/effets des médicaments et des substances chimiques; Hépatocytes/métabolisme; Hépatocytes/anatomopathologie; Humains; Médiateurs de l'inflammation/métabolisme; Interleukine-11/métabolisme; Sous-unité alpha du récepteur à l'interleukine-11/déficit; Sous-unité alpha du récepteur à l'interleukine-11/génétique; Foie/métabolisme; Foie/anatomopathologie; Cirrhose expérimentale/génétique; Cirrhose expérimentale/métabolisme; Cirrhose expérimentale/anatomopathologie; Mâle; Souris de lignée C57BL; Souris knockout; Stéatose hépatique non alcoolique/génétique; Stéatose hépatique non alcoolique/métabolisme; Stéatose hépatique non alcoolique/anatomopathologie; Transduction du signal/effets des médicaments et des substances chimiques; Cellules THP-1
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Interleukine-11 / Sous-unité alpha du récepteur à l'interleukine-11 / Anticorps neutralisants / Stéatose hépatique non alcoolique / Hépatite / Foie / Cirrhose expérimentale Type d'étude: Prognostic_studies Langue: En Journal: Gastroenterology Année: 2019 Type de document: Article Pays d'affiliation: Singapour Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Interleukine-11 / Sous-unité alpha du récepteur à l'interleukine-11 / Anticorps neutralisants / Stéatose hépatique non alcoolique / Hépatite / Foie / Cirrhose expérimentale Type d'étude: Prognostic_studies Langue: En Journal: Gastroenterology Année: 2019 Type de document: Article Pays d'affiliation: Singapour Pays de publication: États-Unis d'Amérique